4.20000 USD
0.16
3.67%
Last update Dec 15, 11:51 AM EST
Pre-market
Day range
4.20000
4.45000
Previous close
4.36000
Open
4.45000
Access this stock data via API
Subscribe
NervGen Pharma Corp.
4.20
0.16
3.67%

Financials

Income statement

Fundamentals currency is CAD
Fiscal date 2024 2023 2022 2021
Total reported revenue 0 0 0 0
Cost of revenue
Gross profit
Operating expense
Research & development 11.4M 8.0M 16.6M 6.9M
Selling general and admin 6.7M 9.6M 6.3M 5.9M
Other operating expenses
Operating income -18.1M -17.8M -23.0M -12.8M
Non operating interest income
Income 590.3K 550.1K 201.4K 29.4K
Expense 0 514.6K 0
Other income expense 82.4K -5.2M 2.6M 55.2K
Pretax income -17.4M -22.4M -20.7M -12.7M
Tax provision
Net income -17.4M -22.4M -20.7M -12.7M
Basic EPS -0.4 -0.4 -0.4 -0.3
Diluted EPS -0.4 -0.4 -0.4 -0.3
Basic average shares 48.9M 84.2M 76.5M 57.1M
Diluted average shares 48.9M 84.2M 76.5M 57.1M
EBITDA -18.1M -17.1M -22.7M -12.7M
Net income from continuing op. -17.4M -22.4M -20.7M -12.7M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Pre-market

Exchange is currently open for pre-market.
Main market opens in 3 hours 28 minutes

06:01
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
06:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 17:00
All times are displayed in the America/New_York timezone (EST, UTC-05:00).